PhorMed
Join Us in the Fight to Cure Cancer! Pre-Public Limited Time Offer *10% Bonus Discount*
https://wefunder.com/phormed
Total raised on Wefunder: 204025
Total investors: 228
Quick facts
- In a clinical study, we helped 83% of patients beat cancer
- Our drug repairs damaged cells and kills cancer
- On a mission to bring new hope and a brighter future to patients battling life-threatening diseases
- $3.5 million raised from >4,100 investors: Crowdfunding and Angel investors
- Undervalued position, potential to buy low/sell high. PhorMed = $53M; Similar Companies = $290M-1.2B
- FDA allowing “FAST-TRACKING” clinical studies = huge time & cost savings
- Our team has 533 peer-reviewed publications
- Company is ready to start three phase 2 studies